Antibiotic Treatment foLlowing surgical drAinage of perianal abScess (ATLAS): protocol for a multicentre, double-blind, placebo-controlled, randomised trial

Justin Y van Oostendorp, Lisette Dekker, Susan van Dieren, Willem A Bemelman, Ingrid J M Han-Geurts, Justin Y van Oostendorp, Lisette Dekker, Susan van Dieren, Willem A Bemelman, Ingrid J M Han-Geurts

Abstract

Introduction: Perianal fistula is a burdening disease with an annual incidence of 6-12/100 000 in Western countries. More than 90% of crypto-glandular fistulas originate from perianal abscess. Despite adequate drainage, up to 83% recur or result in an anal fistula, the majority developing within 12 months. There is some evidence that gut-derived bacteria play a role in the development of perianal fistula. Up till now, it is not common practice to routinely administer prophylactic antibiotics to prevent anal fistula development. There is a need for a study to establish whether adding antibiotic treatment to surgical drainage of perianal abscess results in a reduction in perianal fistulas.

Methods and analysis: This multicentre, double-blind, randomised, placebo-controlled trial investigates whether addition of antibiotics (ciprofloxacin and metronidazole) to surgical drainage of a perianal abscess is beneficial compared with surgical drainage alone. The primary outcome is the development of a perianal fistula within 1 year. Secondary outcomes include quality of life, treatment costs, need for repeated drainage, patient-reported outcomes and other clinical outcomes. Participants are recruited in one academic and seven peripheral Dutch clinics. To demonstrate a reduction of perianal fistula from 30% to 15% when treated with adjuvant antibiotics with a two-sided alpha of 0.05, a power of 80% and taking a 10% loss to follow-up percentage into account, the total sample size will be 298 participants. Data will be analysed according to the intention-to-treat principle.

Ethics and dissemination: The study protocol has been approved by the Medical Ethics Review Committee of the Amsterdam University Medical Centers (nr. 2021_010). Written consent is obtained from each participant prior to randomisation into the study. The results of this trial will be submitted for publication in international peer-reviewed journals, presented at conferences and spread to coloproctological associations.

Trial registration numbers: 2020-004449-35; NCT05385887.

Keywords: colorectal surgery; health economics; surgery.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Sainio P. Fistula-In-Ano in a defined population. incidence and epidemiological aspects. Ann Chir Gynaecol 1984;73:219–24.
    1. Nelson R. Anorectal abscess fistula: what do we know? Surg Clin North Am 2002;82:1139–51. v-vi. 10.1016/S0039-6109(02)00063-4
    1. Open dis data. Available:
    1. Oliver I, Lacueva FJ, Pérez Vicente F, et al. . Randomized clinical trial comparing simple drainage of anorectal abscess with and without fistula track treatment. Int J Colorectal Dis 2003;18:107–10. 10.1007/s00384-002-0429-0
    1. Hamadani A, Haigh PI, Liu I-LA, et al. . Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess? Dis Colon Rectum 2009;52:217–21. 10.1007/DCR.0b013e31819a5c52
    1. Fielding MA, Berry AR. Management of perianal sepsis in a district general Hospital. J R Coll Surg Edinb 1992;37:232–4.
    1. Mocanu V, Dang JT, Ladak F, et al. . Antibiotic use in prevention of anal fistulas following incision and drainage of anorectal abscesses: a systematic review and meta-analysis. Am J Surg 2019;217:910–7. 10.1016/j.amjsurg.2019.01.015
    1. Sözener U, Gedik E, Kessaf Aslar A, et al. . Does adjuvant antibiotic treatment after drainage of anorectal abscess prevent development of anal fistulas? A randomized, placebo-controlled, double-blind, multicenter study. Dis Colon Rectum 2011;54:923–9. 10.1097/DCR.0b013e31821cc1f9
    1. Ghahramani L, Minaie MR, Arasteh P, et al. . Antibiotic therapy for prevention of fistula in-ano after incision and drainage of simple perianal abscess: a randomized single blind clinical trial. Surgery 2017;162:1017–25. 10.1016/j.surg.2017.07.001
    1. Vogel JD, Johnson EK, Morris AM, et al. . Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal fistula. Dis Colon Rectum 2016;59:1117–33. 10.1097/DCR.0000000000000733
    1. Ommer A, Herold A, Berg E, et al. . German S3 guidelines: anal abscess and fistula (second revised version). Langenbecks Arch Surg 2017;402:191–201. 10.1007/s00423-017-1563-z
    1. Lundqvist A, Ahlberg I, Hjalte F, et al. . Direct and indirect costs for anal fistula in Sweden. Int J Surg 2016;35:129–33. 10.1016/j.ijsu.2016.09.082
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . Spirit 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Whiting JL, Cheng N, Chow AW. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria. Antimicrob Agents Chemother 1987;31:1379–82. 10.1128/AAC.31.9.1379
    1. Vander Mijnsbrugge GJ, Molenaar C, Buyl R, et al. . How is your proctology patient really doing? Outcome measurement in proctology: development, design and validation study of the Proctoprom. Tech Coloproctol 2020;24:291–300. 10.1007/s10151-020-02156-2
    1. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13. 10.1097/
    1. Hämäläinen KP, Sainio AP. Incidence of fistulas after drainage of acute anorectal abscesses. Dis Colon Rectum 1998;41:1357–61. 10.1007/BF02237048
    1. Lohsiriwat V, Yodying H, Lohsiriwat D. Incidence and factors influencing the development of fistula-in-ano after incision and drainage of perianal abscesses. J Med Assoc Thai 2010;93:61–5.
    1. Hakkaart-van Roijen L, Essink-Bot M-L. Manual health and labour questionnaire. Institute for Medical Technology Assessment (iMTA), 2000.
    1. M Versteegh M, M Vermeulen K, M A A Evers S, et al. . Dutch tariff for the five-level version of EQ-5D. Value Health 2016;19:343–52. 10.1016/j.jval.2016.01.003
    1. Sullivan SD, Mauskopf JA, Augustovski F, et al. . Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II Task force. Value Health 2014;17:5–14. 10.1016/j.jval.2013.08.2291
    1. Goettsch WG, Enzing J. Review: report of the ISPOR 2012 budget impact analysis good practice II Task force. Value Health 2014;17:1–2. 10.1016/j.jval.2013.09.003

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi